Sign up
All cardiology trends
RisingCardiology · updated 18 Oct 2026

ATTR amyloid cardiomyopathy

Heart disease caused by transthyretin amyloid deposits, and its diagnosis and treatment.

55PubDaily Trend Score
+26%new papers vs last year
37new trials registered
2new guidelines this year

Papers per year

Each bar is 12 months; the last one ends 17 Oct 2026. New trials in the same years: 23, 26, 34, 35, 37.

New guidelines and consensus this year

  1. Transthyretin Cardiac Amyloidosis Evaluation and Management: 2025 ACC Concise Clinical Guidance
    J Am Coll Cardiol2026 Feb 10
  2. Non-amyloid specific treatment for transthyretin cardiac amyloidosis: a clinical consensus statement of the ESC Heart Failure Association
    Eur Heart J2026 Jan 5

All papers from the last 12 months

1,103 papers (18 Oct 2025 – 17 Oct 2026), newest first. Loading the full list…

Open this search in PubMed
  1. Cas12a chRDNA-mediated in vivo genome editing for high specificity functional gene disruption
    Mol Ther Nucleic Acids2026 Dec 8PMID 42780917
  2. External validation of the RAISE score for the diagnosis of transthyretin cardiac amyloidosis in patients with severe aortic stenosis. AMYLOCOR registry
    Int J Cardiol2026 Dec 1PMID 42754100
  3. Valve diseases in cardiac amyloidosis: What we have to know
    Curr Probl Cardiol2026 DecPMID 42727900Review
  4. Does human transthyretin aggregate in blood plasma or in cardiac tissue? A mathematical modeling study
    J Theor Biol2026 Nov 7PMID 42600979
  5. The pathophysiology of wild-type transthyretin amyloidosis: implications for exercise intolerance
    Am J Physiol Heart Circ Physiol2026 Nov 1PMID 42886507Review
  6. Early-Onset Wild-Type Transthyretin Amyloidosis Polyneuropathy
    Muscle Nerve2026 NovPMID 42637685
  7. Impact of amyloid cardiomyopathy diagnosis on heart failure readmission and length of stay
    Proc (Bayl Univ Med Cent)2026 NovPMID 42635388
  8. Development of a Three-Source Convergent Risk Assessment Tool for Amyloidosis Screening in Carpal Tunnel Syndrome Patients
    J Hand Surg Glob Online2026 NovPMID 42604118
  9. Worsening heart failure and mortality in patients with transthyretin cardiac amyloidosis: The predictive role of frailty
    Int J Cardiol2026 Nov 1PMID 42580556
  10. Mefenamic acid attenuates NLRP3-associated neuroinflammation and mitochondrial dysfunction and is associated with prevention of long-term cognitive impairment after sepsis
    J Neuroimmunol2026 NovPMID 42492334

More cardiology trends

All specialties →

Too many papers to read?

PubDaily picks the ones that matter in your specialty and summarises them, about 10 minutes a week.

Get started
How these numbers are counted

PubMed query, searched in titles and abstracts by publication date:

transthyretin[tiab] AND (cardiomyopathy[tiab] OR amyloid*[tiab])

Trials: ClinicalTrials.gov studies first submitted in each 12-month window that match the same terms. A query can miss synonyms or catch unrelated papers, so treat counts as approximate.